Healthequity Inc
F:2HE

Watchlist Manager
Healthequity Inc Logo
Healthequity Inc
F:2HE
Watchlist
Price: 70 EUR 0.72% Market Closed
Market Cap: €6.1B

Healthequity Inc
Investor Relations

Healthequity helps employers and their workers manage health savings accounts and other tax-advantaged healthcare spending accounts. It provides the account administration, recordkeeping, debit cards, online tools, and payment processing that let people save for medical expenses and pay eligible bills. It also offers ways to invest balances once they grow large enough, usually through partner investment platforms. Its main customers are employers, health plans, benefits brokers, and individual account holders who need a simple way to manage healthcare money. Employers and benefits partners use Healthequity’s system to offer these accounts as part of employee benefits, while workers use it to pay for care, track claims, and invest unused funds. The company makes money mainly from administration and service fees, plus asset-based and transaction-related fees tied to account activity. What makes Healthequity different is its role as the financial backbone for consumer-directed healthcare accounts. It sits between the employer, the employee, the health plan, and the payment network, making a complicated set of tax and payment rules easier to use. In simple terms, it sells the infrastructure that keeps these accounts compliant, usable, and connected to everyday healthcare spending.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2026
Call Date
Mar 17, 2026
AI Summary
Q4 2026

Revenue & Profit: Q4 revenue was $334.6 million (up 7% YoY); Q4 GAAP net income was $49.7 million ($0.58 per share), and fiscal 2026 net income was $215.2 million ($2.46 per share).

Margins: Q4 gross margin expanded to 68% (up ~700 bps YoY) and adjusted EBITDA margin widened to 40% in Q4; fiscal 2026 adjusted EBITDA margin was 43%.

HSA Growth: Added a record 550,000 HSAs in Q4 and more than 1 million for the year, bringing total accounts to 17.8 million and HSA assets to more than $36 billion (up 14% YoY).

Operational wins: Fraud reimbursements were approximately $0.3 million in Q4 (exit run rate 0.1 basis points for the quarter); fiscal-year fraud cost ~1.1 basis points. Service costs fell ~$17 million YoY in Q4.

Product & AI: Launched a marketplace (initial offerings: weight loss/GLP-1 programs, hormone replacement therapy, wearables) and are embedding AI across member experience, operations and personalization to drive engagement and lower cost to serve.

Balance sheet & capital return: Ended the quarter with $319 million cash, generated $457 million cash from operations in fiscal 2026, repurchased >$300 million of stock in the year (about $82 million in Q4) and have ~$178 million remaining on the repurchase authorization.

Raised outlook: Fiscal 2027 revenue guidance raised to $1.405–$1.415 billion; GAAP net income guidance raised to $239–$246 million ($2.78–$2.85 per share).

Key Financials
Revenue (Q4)
$334.6 million
Revenue (Fiscal 2026)
$1.313 billion
GAAP net income (Q4)
$49.7 million
GAAP net income per diluted share (Q4)
$0.58
GAAP net income (Fiscal 2026)
$215.2 million
GAAP net income per diluted share (Fiscal 2026)
$2.46
Adjusted EBITDA (Q4)
$132.9 million
Adjusted EBITDA (Fiscal 2026)
$566 million
Gross profit (Q4)
$228.1 million
Gross margin (Q4)
68%
Adjusted EBITDA margin (Q4)
40%
Adjusted EBITDA margin (Fiscal 2026)
43%
Total accounts
17.8 million
HSAs added (Q4)
550,000
HSAs added (Fiscal 2026)
more than 1 million from sales
HSA Assets
more than $36 billion
HSA cash yield (Q4 annualized)
3.57%
Average HSA cash yield (Fiscal 2026)
3.53%
Expected average HSA cash yield (Fiscal 2027)
approximately 3.8%
Interchange revenue (Q4)
$46.1 million
Service revenue (Q4)
$127.1 million
Custodial revenue (Q4)
$161.4 million
App downloads
more than 3.6 million
Fraud reimbursements (Q4)
approximately $0.3 million
Fiscal-year fraud cost
approximately 1.1 basis points
Cash on hand
$319 million
Cash flow from operations (Fiscal 2026)
$457 million
Debt outstanding (net)
approximately $957 million
Share repurchases (Fiscal 2026)
more than $300 million
Share repurchases (Q4)
approximately $82 million
Remaining repurchase authorization
approximately $178 million
Diluted share count used in guidance
86 million (estimated)
Forward interest-rate contracts notional
approximately $2.4 billion
Forward interest-rate contracts blended rate lock
3.92%
Fiscal 2027 revenue guidance
$1.405 billion to $1.415 billion
Fiscal 2027 GAAP net income guidance
$239 million to $246 million
Fiscal 2027 GAAP net income per diluted share guidance
$2.78 to $2.85
Fiscal 2027 adjusted EBITDA guidance
$618 million to $628 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Jon Kessler
President, CEO & Director
No Bio Available
Dr. Stephen D. Neeleman
Founder & Vice Chairman
No Bio Available
Mr. James M. Lucania
CFO & Executive VP
No Bio Available
Mr. Elimelech Rosner
Executive VP & CTO
No Bio Available
Mr. Delano Ladd J.D.
Executive VP, General Counsel & Secretary
No Bio Available
Mr. Richard Putnam
Vice President of Investor Relations
No Bio Available
Mr. Steve Lindsay
Executive Vice President of Sales & Relationship Management
No Bio Available
Mr. Brad Bennion
Executive Vice President of Corporate Development & Strategy
No Bio Available
Ms. Tia Padia
Executive VP & Chief Marketing Officer
No Bio Available
Cheryl King
Executive VP & Chief People Officer
No Bio Available

Contacts

Address
UTAH
Draper
15 W Scenic Pointe Dr Ste 100
Contacts
+18017271000.0
healthequity.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett